Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Chemistry

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1373/clinchem.2012.194167PMID 23288489PMCID PMC3694412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.

  2012cited by this paper
• Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies

  2011cited by this paper
• A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.

  2011cited by this paper
• A map of human genome variation from population-scale sequencing

  2010cited by this paper
• The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function.

  2010cited by this paper
• Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes

  2010cited by this paper
• The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects.

  2009cited by this paper
• Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure

  2009cited by this paper
• Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity

  2009cited by this paper
• Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

  2009cited by this paper
• Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor.

  2009cited by this paper
• Analyses and Comparison of Accuracy of Different Genotype Imputation Methods

  2008cited by this paper
• Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women.

  2008cited by this paper
• Accuracy of Administrative Coding for Type 2 Diabetes in Children, Adolescents, and Young Adults

  2007cited by this paper
• A second generation human haplotype map of over 3.1 million SNPs

  2007cited by this paper
• Computational methods for case-cohort studies

  2007cited by this paper
• Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals

  2007cited by this paper
• Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations.

  2007cited by this paper
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

  2006cited by this paper
• An Unsuspected Metabolic Role for Atrial Natriuretic Peptides: The Control of Lipolysis, Lipid Mobilization, and Systemic Nonesterified Fatty Acids Levels in Humans

  2005cited by this paper
• N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic Syndrome

  2005cited by this paper
• The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

  2004cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• Exposure Stratified Case-Cohort Designs

  2000cited by this paper
• Natriuretic peptides: a new lipolytic pathway in human adipocytes

  2000cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Natriuretic peptides.

  1998cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• Robust variance estimation for the case-cohort design.

  1994cited by this paper
• A case-cohort design for epidemiologic cohort studies and disease prevention trials

  1986cited by this paper
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

  1981cited by this paper
• A Generalization of Sampling Without Replacement from a Finite Universe

  1952cited by this paper

• The Genetic Polymorphisms of NPPA:rs5065 and NPPB:rs198389 and Intermediate Phenotypes of Heart Failure in Polish Patients

  2025influential citation
• Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis

  2024cites this paper
• Subclinical Cardiovascular Disease in US Adults With and Without Diabetes

  2023cites this paper
• Diabetes mellitus status modifies the association between N-terminal B-type natriuretic peptide and all-cause mortality risk in ischemic heart failure: a prospective cohort study

  2023cites this paper
• CLINICAL SIGNIFICANCE OF NATRIURETIC PEPTIDES (review)

  2022cites this paper
• Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials

  2022cites this paper
• Six‐year changes in N‐terminal pro‐brain natriuretic peptide and changes in weight and risk of obesity

  2021cites this paper
• Prognostic Significance of Preprocedural N-Terminal Pro-B-Type Natriuretic Peptide Assessment in Diabetic Patients With Multivessel Coronary Disease Undergoing Revascularization

  2021cites this paper
• Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium

  2021cites this paper
• STOP-HF Trial

  2021cites this paper
• Fatty Liver Is Associated with Low N-Terminal Pro-B-Type Natriuretic Peptide in a Healthy Population

  2021cites this paper
• Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications

  2020cites this paper
• NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?

  2020cites this paper
• Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control

  2020cites this paper
• Circulating B‐type natriuretic peptide in women with and without recent gestational diabetes: The impact of current glucose intolerance

  2018cites this paper
• Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis

  2017influential citation
• Natriuretic peptides in the control of lipid metabolism and insulin sensitivity

  2017cites this paper
• Use of Biomarkers in Predicting the Onset, Monitoring the Progression, and Risk Stratification for Patients with Type 2 Diabetes Mellitus.

  2017cites this paper
• Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.

  2016cites this paper
• Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis.

  2016cites this paper
• Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.

  2016cites this paper
• MOLECULAR PHYSIOLOGY OF MEMBRANE GUANYLYL CYCLASE RECEPTORS

  2016cites this paper
• Molecular Physiology of Membrane Guanylyl Cyclase Receptors.

  2016cites this paper
• INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist

  2015cites this paper
• Maternal serum atrial natriuretic peptide (ANP) and brain-type natriuretic peptide (BNP) levels in gestational diabetes mellitus

  2015cites this paper
• Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).

  2015cites this paper
• Examination of the brain natriuretic peptide rs198389 single-nucleotide polymorphism on type 2 diabetes mellitus and related phenotypes in an Algerian population.

  2015cites this paper
• Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome.

  2014cites this paper
• Plasma MR-proANP levels are associated with carotid intima-media thickness in the general community: the KORA F4 study.

  2013cites this paper
• Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association

  year unknowncites this paper